From Casetext: Smarter Legal Research

Cambrian Biopharma Inc. v. Brunemeier

United States District Court, S.D. New York
May 31, 2022
22 Civ. 3310 (VM) (S.D.N.Y. May. 31, 2022)

Opinion

22 Civ. 3310 (VM)

05-31-2022

CAMBRIAN BIOPHARMA INC., Plaintiff, v. SEBASTIAN AGUIAR BRUNEMEIER and PANTHEON HOLDING, LLC, Defendants.


ORDER

VICTOR MARRERO, United States District Judge.

The defendants Sebastian Aguiar Brunemeier and Pantheon Holdings, LLC (“Defendants”) assert that the letter, dated May 25, 2022, from plaintiff Cambrian Biopharma Inc. (“Cambrian”) fails to comply with the Court's Individual Practices because Cambrian did address which of the Defendants' objections to the complaint that Cambrian concurs with and which it does not. (Dkt. No. 14.) Cambrian is directed to file a letter, with its amended complaint, that responds to the Defendants' objections. Specifically, Cambrian shall explain how the amended complaint addresses the deficiencies that the Defendants identified.

SO ORDERED.


Summaries of

Cambrian Biopharma Inc. v. Brunemeier

United States District Court, S.D. New York
May 31, 2022
22 Civ. 3310 (VM) (S.D.N.Y. May. 31, 2022)
Case details for

Cambrian Biopharma Inc. v. Brunemeier

Case Details

Full title:CAMBRIAN BIOPHARMA INC., Plaintiff, v. SEBASTIAN AGUIAR BRUNEMEIER and…

Court:United States District Court, S.D. New York

Date published: May 31, 2022

Citations

22 Civ. 3310 (VM) (S.D.N.Y. May. 31, 2022)